Slideshow: in de kijker


Het project Gerodent van het UZ Gent trekt sinds 2010 naar woonzorgcentra en verleent er curatieve en preventieve mondzorg.

Lees meer


Het UZ Gent is vlot bereikbaar. Op de campus maakt een routesysteem u wegwijs.

Lees meer

U bent hier: Skip Navigation LinksUZ Gent > Home > Agenda

Internationaal symposium: Primaire levertumoren

Tijdstip:

31 augustus 2017 11u15 - 01 september 2017 16u45

Doelgroep:

Chirurgen, hepatologen, radiologen en oncologen

Locatie:

Dept. of Surgery, Erasmus MC, PO Box 2040, 3000 CA Rotterdam

Contact persoon:

HPBRotterdam@erasmusmc.nl

Programma:

​Program:

Day 1, Thursday August 31 2017

  • 11.15-11.45 am: Welcome reception

  • 11.45-12.00 am: Welcome address - Jan Ijzermans, Rotterdam, The Netherlands and Rob de Man, Rotterdam, The Netherlands

  • 12.00-2.00 pm: Session 1: Hepatocellular carcinoma
    Chairs: Massimo Colombo, Milan Italy and Rob de Man, Rotterdam, The Netherlands

    • 12.00-12.30 pm: Epidemiology and screening of HCC - Massimo Colombo, Milan, Italy

    • 12.30-1.00 pm: Accuracy of imaging modalities - Francois Willemssen, Rotterdam, The Netherlands

    • 1.00-1.30 pm: BCLC criteria vs other prognostic systems for HCC patients. Western perspective - Umberto Cillo, Padova, Italy

    • 1.30-2.00 pm: Predicting HCC development - Philip Johnson, Liverpool, UK

  • 2.00-2.30 pm: Coffe break

  • 2.30-4.30 pm: Session 2: Surgical Treatment for HCC
    Chairs: Masatoshi Makuuchi, Tokyo, Japan and Wojcciech Polak, Rotterdam, The Netherlands

    • 2.30-3.00 pm: Riskassesment before liver surgery for HCC incirrhotic patients - Thomas Van Gulik, Amsterdam, The Netherlands

    • 3.00-3.30 pm: Boundaries in liver resection for HCC - Masatoshi Makuuchi, Tokyo, Japan

    • 3.30-4.00 pm: Deceased donor liver transplantation for HCC - Rene Adam, Paris, France

    • 4.00-4.30 pm: Living donor liver transplantation for HCC - Dieter Broering, Riyadh, Saudi Arabia

  • 4.30-5.00 pm: Coffee break

  • 5.00-7.30 pm: Session 3: Loco-regional Treatment in HCC
    Chairs: Bruno Sangro, Navarro, Spain and Adriaan Moelker, Rotterdam, The Netherlands

    • 5.00-5.30 pm: Advances and limitations ablation techniques for HCC - Otto van Delden, Amsterdam, The Netherlands

    • 5.30-6.00 pm: Transarterial radioembolisation - how does it affect our daily practice - Bruno Sangro, Navara, Spain

    • 6.00-6.30 pm: The role of TACE in the SIRT era - Adriaan Moelker, Rotterdam, The Netherlands

  • 7.30-22.30 pm: Networking

Day 2, Friday September 1 2017


  • 8.30-10.30 am: Session 4: Emerging Therapies for HCC
    Chairs: Alejandro Forner, Barcelona, Spain and Dave Sprengers, Rotterdam, The Netherlands

    • 8.30-9.00 am: Radiotherapy for HCC - Thomas Brunner, Freiburg, Germany

    • 9.00-9.30 am: Is proton therapy the new radiotherapy for HCC? - Alejandra Mendez Romero, Rotterdam, The Netherlands

    • 9.30-10.00 am: Immunotherapy in the treatment of HCC - Dave Sprengers, Rotterdam, The Netherlands

    • 10.00-10.30 am: Progress in systemic therapy of advanced hepatocellular carcinoma - Alejandro Forner, Barcelona, Spain

  • 10.30-11.00 am: Coffe break

  • 11.00-1.30 pm: Session 5: Innovations in Liver Tumor Diagnostics
    Chairs: Dan G. Duda, Boston, USA and Jan Ijzermans, Rotterdam, The Netherlands

    • 11.00-11.30 am: Diagnostic dilemmas in liver tumors - Valerie Vilgrain, Paris, France

    • 11.30-12.30 pm: Translation from molecular biology to clinical practice - Jessica Zucman-Rossi, Paris, France

    • 12.30-1.00 pm: The role of translational studies in clinical trials of liver cancers - Dan G. Duda, Boston, USA

    • 1.00-1.30 pm: Personalized approach using organoids in the treatment of liver tumors - Meritxell Huch, Utrecht, The Netherlands

  • 1.30-2.30 pm: Lunch

  • 2.30-4.30 pm: Session 6: Cholangiocarcinoma
    Chairs: ChristianToso, Geneva, Switzerland and Bas Groot Koerkamp, Rotterdam, The Netherlands

    • 2.30-3.00 pm: Epidemiology of hilar cholangiocarcinoma - Sarwa Darwish Murad, Rotterdam, The Netherlands

    • 3.00-3.30 pm: Difficulties in preoperative tumor assessment in hilar cholangiocarcinoma - Bas Groot Koerkamp, Rotterdam, The Netherlands

    • 3.30-4.00 pm: Surgical treatment of hilar cholangiocarcinoma (resection, ITx) - Christian Toso, Geneva, Switzerland

    • 4.00-4.30 pm: Advances in systemic therapy for cholangiocarcinoma - Arndt Vogel, Hannover, Germany

    • 4.30-4.45 pm: Closing remarks

  • 4.45 pm: Farewell

Practical:

U kan zich inschrijven via het inschrijvingsformulier
Meer info vindt u in de uitnodiging